{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:49:53Z","timestamp":1768470593918,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.tube.2016.09.025","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T14:06:06Z","timestamp":1475244366000},"page":"S73-S77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S","title":["Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"101","author":[{"given":"Sarah F.","family":"John","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Aniemeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngan P.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis R.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Graviss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun O.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omonike A.","family":"Olaleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.09.025_bib1","unstructured":"World Health Organization (WHO). Tuberculosis fact sheet. www.who.int\/mediacentre\/factsheets\/fs104\/en\/."},{"key":"10.1016\/j.tube.2016.09.025_bib2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.09.025_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A\u00a0prospective study of the risk of tuberculosis among intravenous drug users with human immunode\ufb01ciency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tube.2016.09.025_bib4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1472-9792(09)70013-7","article-title":"Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis","volume":"89","author":"Olaleye","year":"2009","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.tube.2016.09.025_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cen.12269","article-title":"How best to approach endocrine evaluation in patients with HIV in the era of combined antiretroviral therapy?","volume":"79","author":"Wren","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.tube.2016.09.025_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccm.2013.02.003","article-title":"Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment","volume":"34","author":"Dierberg","year":"2013","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.tube.2016.09.025_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4103\/0971-5916.92630","article-title":"Diagnosis & treatment of tuberculosis in HIV co-infected patients","volume":"134","author":"Padmapriyadarsini","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tube.2016.09.025_bib8","series-title":"Guidelines on the management of latent tuberculosis infection","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.tube.2016.09.025_bib9","unstructured":"Overview of HIV treatments. http:\/\/aids.gov\/hiv-aids-basics\/just-diagnosed-with-hiv-aids\/treatment-options\/overview-of-hiv-treatments\/[accessed 14.08.07]."},{"key":"10.1016\/j.tube.2016.09.025_bib10","series-title":"The TB and HIV syndemic: prevention, detection, and treatment","first-page":"63","author":"Ebeid","year":"2013"},{"key":"10.1016\/j.tube.2016.09.025_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"19","author":"Klopper","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tube.2016.09.025_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4838(99)00271-X","article-title":"Structure and function of the methionine aminopeptidases","volume":"1477","author":"Lowther","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.tube.2016.09.025_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/emboj\/cdg007","article-title":"Control of protein life-span by N-terminal methionine excision","volume":"22","author":"Giglione","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.tube.2016.09.025_bib14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00018-004-3466-8","article-title":"Protein N-terminal methionine excision","volume":"61","author":"Giglione","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tube.2016.09.025_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1006\/jmbi.1999.2913","article-title":"Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal","volume":"290","author":"Solbiati","year":"1999","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.tube.2016.09.025_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/j.1460-2075.1994.tb06335.x","article-title":"Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation","volume":"13","author":"Mazel","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.tube.2016.09.025_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2174\/0929867054367194","article-title":"Bacterial peptide deformylase inhibitors: a new class of antibacterial agents","volume":"12","author":"Jain","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.tube.2016.09.025_bib18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/AAC.45.4.1058-1064.2001","article-title":"Peptide deformylase as an antibacterial drug target: target validation and resistance development","volume":"45","author":"Apfel","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"44","key":"10.1016\/j.tube.2016.09.025_bib19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1128\/AAC.44.7.1825-1831.2000","article-title":"Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene","volume":"2000","author":"Margolis","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.09.025_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chembiol.2009.12.014","article-title":"Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets","volume":"17","author":"Olaleye","year":"2010","journal-title":"Chem Biol"},{"issue":"8","key":"10.1016\/j.tube.2016.09.025_bib21","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.ejmech.2011.04.056","article-title":"Growth inhibition of Escherichia coli and methicillin-resistant Staphylococcus aureus by targeting cellular methionine aminopeptidase","volume":"46","author":"Chai","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.tube.2016.09.025_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152610791163363","article-title":"Aminopeptidases of malaria parasites: new targets for chemotherapy","volume":"10","author":"Trenholme","year":"2010","journal-title":"Infect Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.tube.2016.09.025_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bmcl.2008.11.098","article-title":"Synthesis and evaluation of 2-pyridyl pyrimidines with in\u00a0vitro antiplasmodial and antileishmanial activity","volume":"19","author":"Musonda","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2016.09.025_bib24","first-page":"907","article-title":"Type 1 methionine aminopeptidase from Saccharomyces cerevisiae is a potential target for antifungal drug screening","volume":"25","author":"Chen","year":"2004","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"10.1016\/j.tube.2016.09.025_bib25","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.bmcl.2013.03.068","article-title":"Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors","volume":"23","author":"Sun","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"Suppl 2","key":"10.1016\/j.tube.2016.09.025_bib26","first-page":"29","article-title":"Methionine aminopeptidase as a novel target for antibiotic therapy against Staphylococcus aureus: a proteomic approach","volume":"17","author":"Kao","year":"2011","journal-title":"Hong Kong Med J"},{"issue":"24","key":"10.1016\/j.tube.2016.09.025_bib27","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/jnci\/djq457","article-title":"Effect of nitroxoline on angiogenesis and growth of human bladder cancer","volume":"102","author":"Shim","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.tube.2016.09.025_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-4598-8-65","article-title":"NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells","volume":"8","author":"Selvakumar","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.tube.2016.09.025_bib29","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1073\/pnas.0404105101","article-title":"A\u00a0methionine aminopeptidase-2 inhibitor, PPI-2458, for treatment of rheumatioid arthritis","volume":"101","author":"Bernier","year":"2004","journal-title":"PNAS"},{"issue":"Suppl 1","key":"10.1016\/j.tube.2016.09.025_bib30","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.tube.2011.10.012","article-title":"Characterization of Clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis","volume":"91","author":"Olaleye","year":"2011","journal-title":"Tuberc (Edinb)"},{"key":"10.1016\/j.tube.2016.09.025_bib31","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/cr0101757","article-title":"Metalloaminopeptidases: common functional themes in disparate structural surroundings","volume":"102","author":"Lowther","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.tube.2016.09.025_bib32","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/jb.171.7.4071-4072.1989","article-title":"Methionine aminopeptidase gene of Escherichia coli is essential for cell growth","volume":"171","author":"Chang","year":"1989","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.tube.2016.09.025_bib33","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1128\/jb.171.9.5215-5217.1989","article-title":"pepM is an essential gene in Salmonella typhimurium","volume":"171","author":"Miller","year":"1989","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.tube.2016.09.025_bib34","doi-asserted-by":"crossref","first-page":"12357","DOI":"10.1073\/pnas.92.26.12357","article-title":"Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases","volume":"92","author":"Li","year":"1995","journal-title":"PNAS"},{"key":"10.1016\/j.tube.2016.09.025_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0304-4165(88)90197-3","article-title":"Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes","volume":"967","author":"Ponka","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.tube.2016.09.025_bib36","first-page":"3574","article-title":"Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase","volume":"7","author":"Green","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tube.2016.09.025_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1357-2725(03)00248-6","article-title":"Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites","volume":"36","author":"Walcourt","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.tube.2016.09.025_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2007.06.011","article-title":"Iron chelators ICL670 and 311 inhibit HIV-1 transcription","volume":"367","author":"Debebe","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.tube.2016.09.025_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/abio.2000.4513","article-title":"Two continuous spectrophotometric assays for methionine aminopeptidase","volume":"280","author":"Zhou","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1016\/j.tube.2016.09.025_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/mol.113.090357","article-title":"Potent antimycobacterial activity of the pyridoxal isonicotinoyl hydrazone analog 2-Pyridylcarboxaldehyde isonicotinoyl hydrazone: a lipophilic transport vehicle for isonicotinic acid hydrazide","volume":"85","author":"Ellis","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.tube.2016.09.025_bib41","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1039\/c3cs60385g","article-title":"Hydrazone-based switches, metallo-assemblies and sensors","volume":"43","author":"Su","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.tube.2016.09.025_bib42","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1073\/pnas.97.3.1252","article-title":"The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages","volume":"97","author":"De Voss","year":"2000","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.tube.2016.09.025_bib43","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/518040","article-title":"The effect of the Host's iron status on tuberculosis","volume":"195","author":"Boelaert","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.09.025_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/mol.110.069062","article-title":"Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-Benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets\u2014iron, cyclin-dependent kinase (CDK) 2, and CDK9","volume":"79","author":"Debebe","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.tube.2016.09.025_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0705089","article-title":"Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents","volume":"138","author":"Becker","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.tube.2016.09.025_bib46","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-2143(99)90173-7","article-title":"Development of novel aroylhydrazone ligands for iron chelation therapy: the 2- pyridylcarboxaldehyde isonicotinoyl hydrazone analogs","volume":"134","author":"Becker","year":"1999","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.tube.2016.09.025_bib47","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V98.3.842","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents IV. The mechanisms involved in inhibiting cell cycle progression","volume":"98","author":"Gao","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tube.2016.09.025_bib48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/cmdc.201100003","article-title":"Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by Bengamide derivatives","volume":"6","author":"Lu","year":"2011","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.tube.2016.09.025_bib49","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1021\/jm901624n","article-title":"Catalysis and inhibition of Mycobacterium tuberculosis methionine aminopeptidase","volume":"53","author":"Lu","year":"2010","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.tube.2016.09.025_bib50","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/AAC.00753-07","article-title":"Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis","volume":"51","author":"Byrne","year":"2007","journal-title":"Antimicrob agents Chemother"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979216304103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979216304103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T04:52:45Z","timestamp":1568436765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979216304103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":50,"alternative-id":["S1472979216304103"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.09.025","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}